3.95 (1.74%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Strong
Earnings
Very Weak
Earnings
Weak
Dividends
Very Weak
Capital Efficiency
Very Strong
Balance Sheet
Strong
Website
Axsome Therapeutics, Inc.
Telephone
1.212.332.3241
Address
29th floor, One World Trade Center, New York, NY 10007
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 96.09 - 235.91
Trade Value (12mth)
US$23,361,964.00
1 week
-0.46%
1 month
23.88%
YTD
26.85%
1 year
114.32%
All time high
235.91
EPS 3 yr Growth
-20.00%
EBITDA Margin
-25.10%
Operating Cashflow
-$93m
Free Cash Flow Return
-38.90%
ROIC
-76.30%
Interest Coverage
-10.10
Quick Ratio
1.50
Shares Outstanding (Fully Diluted)
51m
HALO Sector
Healthcare
Next Company Report Date
01-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 05 May 26 | |
| 05 May 26 | |
| 04 May 26 | |
| 01 May 26 | |
| 01 May 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -5.27 | -5.99 | -3.68 | | | | ||
EPS (Fully Diluted) | $ | | | | | -5.27 | -5.99 | -3.68 | | | | ||
Growth | % | | | | | -14.4 | -13.8 | 38.6 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
